- Home
- GNLN vs SCNI Comparison
GNLN vs SCNI Comparison
Compare GNLN & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- SCNI
- Stock Information
- Founded
- GNLN 2005
- SCNI 2003
- Country
- GNLN United States
- SCNI Israel
- Employees
- GNLN N/A
- SCNI N/A
- Industry
- GNLN Durable Goods
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNLN Consumer Discretionary
- SCNI Health Care
- Exchange
- GNLN Nasdaq
- SCNI Nasdaq
- Market Cap
- GNLN 2.3M
- SCNI 1.9M
- IPO Year
- GNLN 2019
- SCNI N/A
- Fundamental
- Price
- GNLN $0.01
- SCNI $2.55
- Analyst Decision
- GNLN
- SCNI
- Analyst Count
- GNLN 0
- SCNI 0
- Target Price
- GNLN N/A
- SCNI N/A
- AVG Volume (30 Days)
- GNLN 39.7M
- SCNI 18.0K
- Earning Date
- GNLN 03-21-2025
- SCNI 05-14-2025
- Dividend Yield
- GNLN N/A
- SCNI N/A
- EPS Growth
- GNLN N/A
- SCNI N/A
- EPS
- GNLN N/A
- SCNI 8.20
- Revenue
- GNLN $13,275,000.00
- SCNI $452,000.00
- Revenue This Year
- GNLN $1,541.21
- SCNI N/A
- Revenue Next Year
- GNLN N/A
- SCNI N/A
- P/E Ratio
- GNLN N/A
- SCNI $0.30
- Revenue Growth
- GNLN N/A
- SCNI N/A
- 52 Week Low
- GNLN $0.01
- SCNI $1.90
- 52 Week High
- GNLN $21.80
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- GNLN 18.47
- SCNI 45.49
- Support Level
- GNLN $0.21
- SCNI $1.90
- Resistance Level
- GNLN $0.29
- SCNI $2.54
- Average True Range (ATR)
- GNLN 0.03
- SCNI 0.29
- MACD
- GNLN -0.00
- SCNI 0.04
- Stochastic Oscillator
- GNLN 0.32
- SCNI 47.71
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.